tirzepatide fatty liver disease for weight loss treats in Phase 2 trial Tirzepatide for Fatty Liver Disease:

Post-surgical wellness: supportive care during soft tissue and orthopedic recovery periods

101 labeled brain images and a consistent human cortical labeling protocol

Together, we strive to empower women through education, shared decision-making, and compassionate, evidence-based care.

The pharmacy was fined $5,000 and agreed to never reopen or own any facility requiring a Kentucky pharmacy permit

The nuances of social media ephemeral content, slang and innuendo, influencers casually mentioning products during vlogs make it challenging to apply rules that were written with traditional ads in mind

Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, including claims implying sameness with FDA-approved medications